The effects of apomorphine and d-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny

Brain Research

Volumn 1119, Issue 1, 2006, Pages 203-214

  Saint Marie, Richard L ^a   Neary, Alaina C ^a   Shoemaker, Jody M ^a   Swerdlow, Neal R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Apomorphine; c Fos; Nucleus accumbens; Prepulse inhibition; Schizophrenia; Striatum

Indexed keywords

APOMORPHINE; DEXAMPHETAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CONDUCTION; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT;

ANIMALS; APOMORPHINE; BIOLOGICAL MARKERS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGONISTS; DRUG RESISTANCE; FEMALE; IMMUNOHISTOCHEMISTRY; INHERITANCE PATTERNS; MALE; NEOSTRIATUM; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SPECIES SPECIFICITY; STARTLE REACTION; TRANS-ACTIVATION (GENETICS); UP-REGULATION; VARIATION (GENETICS);

EID: 33750483966     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.045     Document Type: Article

References (61)

1. Arnold J.C., Topple A.N., Mallet P.E., Hunt G.E., and McGregor I.S. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res. 921 (2001) 240-255
2. Badiani A., Oates M.M., Day H.E.W., Watson S.J., Akil H., and Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci. 18 (1998) 10579-10593
3. Braff D.L., Stone C., Callaway E., Geyer M., Glick I., and Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15 (1978) 339-343
4. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001) 234-258
5. Brodkin E.S., Carlezon Jr. W.A., Haile C.N., Kosten T.A., Heninger G.R., and Nestler E.J. Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice. Brain Res. 805 (1998) 55-68
6. Canales J.J., and Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 3 (2000) 377-383
7. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., and Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol. Psychiatry 39 (1996) 33-41
8. Chang S.L., Squinto S.P., and Harlan R.E. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157 (1988) 698-704
9. Choe E.S., Chung K.T., Mao L., and Wang J.Q. Amphetamine increases phosphorylation of extracellular signal-related kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27 (2002) 565-575
10. Conversi D., Orsini C., and Cabib S. Distinct patterns of Fos expression induced by systemic amphetamine in the striatal complex of C57BL/6JICo and DAB/2JICo inbred strains of mice. Brain Res. 1025 (2004) 59-66
11. Deutch A.Y. Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. In: Deutch A.Y. (Ed). Handbook of Experimental Pharmacology: Antipsychotics (1996), Springer, Berlin 117-161
12. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37 (1990) 286-294
13. Ferguson S.M., Norton C.S., Watson S.J., Akil H., and Robinson T.E. Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J. Neurochem. 86 (2003) 33-44
14. Francis D.D., Szegda K., Campbell G., Martin W.D., and Insel T.R. Epigenetic sources of behavioral differences in mice. Nat. Neurosci. 6 (2003) 445-446
15. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
16. Grabus S.D., Glowa J.R., and Riley A.L. Morphine- and cocaine-induced c-Fos levels in Lewis and Fischer rat strains. Brain Res. 998 (2004) 20-28
17. Graham F. The more or less startling effects of weak prestimuli. Psychophysiology 12 (1975) 238-248
18. Graybiel A.M., Moratalla R., and Robertson H.A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome matrix compartments of limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6912-6916
19. Haile C.N., Hiroi N., Nestler E.J., and Kosten T.A. Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse 41 (2001) 179-190
20. Harlan R.E., and Garcia M.M. Drugs of abuse and immediate-early genes of the forebrain. Mol. Neurobiol. 16 (1998) 221-267
21. Hart S., Zreik M., Carper R., and Swerdlow N.R. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. Pharmacol. Biochem. Behav. 61 (1998) 113-119
22. Horowitz J.M., Hallas B.H., and Torres G. Rat strain differences to fluoxetine in striatal Fos-like proteins. NeuroReport 13 (2002) 2463-2467
23. Kinney G.G., Wilkinson L.O., Saywell K.L., and Tricklebank M.D. Rat strain differences in ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J. Neurosci. 19 (1999) 5644-5653
24. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol. Behav. 64 (1998) 625-628
25. Kodsi M.H., and Swerdlow N.R. Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res. 643 (1994) 59-65
26. Kodsi M.H., and Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal stiato-pallidal circuitry. Behav. Neurosci. 109 (1995) 912-928
27. Miwa H., Fuwa T., Nishi K., and Mizuno Y. Effects of the globus pallidus lesion on the induction of c-Fos by dopaminergic drugs in the striatum possibly via pallidostriatal feedback loops. Neurosci. Lett. 240 (1998) 167-170
28. Muñoz A., Lopez-Real A., Labandeira-Garcia J.L., and Guerra M.J. Interaction between the noradrenergic and serotinergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats. Exp. Brain Res. 153 (2003) 92-99
29. Oka T., Hamamura T., Lee Y., Miyata S., Habara T., Endo S., Taoka H., and Kuroda S. Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain. Life Sci. 76 (2004) 225-237
30. Palmer A.A., Dulawa S.C., Mottiwala A.A., Conti L.H., Geyer M.A., and Printz M.P. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav. Neurosci. 114 (2000) 373-388
31. Parelkar N.K., and Wang J.Q. mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Mol. Brain Res. 122 (2004) 151-157
32. Patel N., Hitzemann B., and Hitzemann R. Genetics, haloperidol, and Fos response in the basal ganglia: a comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology 18 (1998) 480-491
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. Fourth ed. (1998), Academic Press, San Diego
34. Peng R.Y., Mansbach R.S., Braff D.L., and Geyer M.A. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology 3 (1990) 211-218
35. Rigdon G. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology 102 (1990) 419-421
36. Robertson G.S., Matsumura H., and Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271 (1994) 1058-1066
37. Sills T.L. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res. Bull. 48 (1999) 445-448
38. Steiner H., and Kitai S.T. Regulation of rat cortex function by D1 dopamine receptors in the striatum. J. Neurosci. 20 (2000) 5449-5460
39. Struthers W.M., and Wirtshafter D. Quinpirole attenuates the striatal Fos expression induced by escape behavior. Brain Res. 785 (1998) 347-350
40. Sumner B.E.H., Cruise L.A., Slattery D.A., Hill D.R., Shahid M., and Henry B. Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs. Psychopharmacology 171 (2004) 306-321
41. Swerdlow N.R., Caine S.B., and Geyer M.A. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108 (1992) 189-195
42. Swerdlow N.R., Varty G.B., and Geyer M.A. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat?. Neuropsychopharmacology 18 (1998) 50-56
43. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., Braff D.L., and Geyer M.A. Towards understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J. Neurosci. 20 (2000) 4325-4336
44. Swerdlow N.R., Platten A., Kim Y.K., Gaudet I., Shoemaker J., Pitcher L., and Auerbach P. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Pharmacol. Biochem. Behav. 70 (2001) 219-226
45. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
46. Swerdlow N.R., Shoemaker J.M., Pitcher L., Platten A., Kuczenski R., Eleey C.C., and Auerbach P. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behav. Neurosci. 116 (2002) 682-690
47. Swerdlow N.R., Platten A., Hanlon F.M., Martinez Z.A., Printz M.P., and Auerbach P. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology 28 (2003) 226-234
48. Swerdlow N.R., Shoemaker J.M., Platten A., Pitcher L., Goins J., and Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacol. Biochem. Behav. 75 (2003) 191-197
49. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitcher L., Goins J., and Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating: I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacol. 174 (2004) 441-451
50. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitche L., Goins J., and Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating: II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 174 (2004) 452-462
51. Swerdlow N.R., Shoemaker J.M., Crain S., Goins J., Onozuka K., and Auerbach P.P. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Pharmacol. Biochem. Behav. 77 (2004) 291-302
52. Swerdlow N.R., Kuczenski R., Crain J.C., Ma S.K., Bongiovanni L.T., and Shoemaker M.J. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol. Biochem. Behav. 80 (2005) 203-211
53. Swerdlow N.R., Krupin A.S., Bongiovanni M.J., Shoemaker J.M., Goins J.C., and Hammer Jr. R.P. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Neuropsychopharmacology 31 (2006) 721-729
54. Uslaner J., Badiani A., Day H.E.W., Watson S.J., Akil H., and Robinson T.E. Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res. 920 (2001) 106-116
55. Wan F.J., and Swerdlow N.R. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res. 722 (1996) 168-176
56. 2 modulation of Sensorimotor gating in rats: assessing anatomical localization. Pharmacol. Biochem. Behav. 49 (1994) 155-163
57. Wan F.J., Taaid N., and Swerdlow N.R. Do D1/D2 interactions regulate prepulse inhibition in rats?. Neuropsychopharmacology 14 (1996) 265-274
58. Weiss I.C., Feldon J., and Domeney A.M. Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine. Pharmacol. Biochem. Behav. 64 (1999) 501-505
59. Wirtshafter D. A comparison of the patterns of striatal Fos-like immunoreactivity induced by various dopamine agonists in rats. Neurosci. Lett. 289 (2000) 99-102
60. 2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35 (1994) 85-91
61. 2 receptors in the striatal immediate early gene response to amphetamine in reserpinized rats. Brain Res. Bull. 62 (2003) 77-83